These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1830299)

  • 21. Epstein-Barr virus/complement fragment C3d receptor (CR2) reacts with p53, a cellular antioncogene-encoded membrane phosphoprotein: detection by polyclonal anti-idiotypic anti-CR2 antibodies.
    Barel M; Fiandino A; Lyamani F; Frade R
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10054-8. PubMed ID: 2557614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a spontaneously shed fragment of B cell complement receptor type two (CR2) containing the C3d-binding site.
    Myones BL; Ross GD
    Complement; 1987; 4(2):87-98. PubMed ID: 3497773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of Epstein-Barr virus-binding sites on complement receptor 2 (CR2/CD21) using human-mouse chimeras and peptides. At least two distinct sites are necessary for ligand-receptor interaction.
    Molina H; Brenner C; Jacobi S; Gorka J; Carel JC; Kinoshita T; Holers VM
    J Biol Chem; 1991 Jul; 266(19):12173-9. PubMed ID: 1712014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein Barr virus binding induces internalization of the C3d receptor: a novel immunotoxin delivery system.
    Tedder TF; Goldmacher VS; Lambert JM; Schlossman SF
    J Immunol; 1986 Aug; 137(4):1387-91. PubMed ID: 3016095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens.
    Reynes M; Aubert JP; Cohen JH; Audouin J; Tricottet V; Diebold J; Kazatchkine MD
    J Immunol; 1985 Oct; 135(4):2687-94. PubMed ID: 2411809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of CR2 in the human adult and neonatal in vitro antibody response to type 4 pneumococcal polysaccharide.
    Griffioen AW; Toebes EA; Zegers BJ; Rijkers GT
    Cell Immunol; 1992 Aug; 143(1):11-22. PubMed ID: 1535831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell activation induced by cross-linking CD3 and CD28 leads to silencing of Epstein-Barr virus/C3d receptor (CR2/CD21) gene and protein expression.
    Masilamani M; von Seydlitz E; Bastmeyer M; Illges H
    Immunobiology; 2002 Dec; 206(5):528-36. PubMed ID: 12607728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR; McNaughton ME; Cooper NR
    J Immunol; 1985 Nov; 135(5):3068-73. PubMed ID: 2995485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of CR2 (C3d receptor) on the cell membranes of adult T cell leukemia.
    Kai C; Okada N; Okada H
    Jpn J Cancer Res; 1988 Jul; 79(7):805-8. PubMed ID: 2971638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular interaction of EBV/C3d receptor (CR2) with p68, a calcium-binding protein present in normal but not in transformed B lymphocytes.
    Barel M; Gauffre A; Lyamani F; Fiandino A; Hermann J; Frade R
    J Immunol; 1991 Aug; 147(4):1286-91. PubMed ID: 1831222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CR2 complement receptor.
    Cooper NR; Bradt BM; Rhim JS; Nemerow GR
    J Invest Dermatol; 1990 Jun; 94(6 Suppl):112S-117S. PubMed ID: 2161885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the CD21 antigen in lymphocyte transformation by Epstein-Barr virus.
    Boyd AW; Fecondo J
    Immunol Cell Biol; 1988 Apr; 66 ( Pt 2)():159-65. PubMed ID: 2846436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Epstein-Barr virus receptor on two nasopharyngeal carcinoma model cell lines.
    Takimoto T; Umeda R; Glaser R
    Acta Virol; 1989 Aug; 33(4):375-7. PubMed ID: 2574946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular origins of serum complement receptor type 2 in normal individuals and in hypogammaglobulinaemia.
    Ling N; Hansel T; Richardson P; Brown B
    Clin Exp Immunol; 1991 Apr; 84(1):16-22. PubMed ID: 1849806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement receptor type 1 (C3b/C4b receptor; CD35) and complement receptor type 2 (C3d/Epstein-Barr virus receptor; CD21).
    Fearon DT; Ahearn JM
    Curr Top Microbiol Immunol; 1990; 153():83-98. PubMed ID: 2153507
    [No Abstract]   [Full Text] [Related]  

  • 36. C3d plasma levels and CD21 expressing B-cells in children after ABO-incompatible heart transplantation: Alterations associated with blood group tolerance.
    Urschel S; Ryan LA; Larsen IM; Derkatz K; Rebeyka IM; Ross DB; West LJ
    J Heart Lung Transplant; 2014 Nov; 33(11):1149-56. PubMed ID: 24954883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistology of lymphoid and non-lymphoid cells in the thymus in relation to T lymphocyte differentiation.
    Van Ewijk W
    Am J Anat; 1984 Jul; 170(3):311-30. PubMed ID: 6332520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement C3d,g/Epstein-Barr virus receptor density on human B-lymphocytes estimated by immunoenzymatic assay and immunocytochemistry.
    Rask R; Rasmussen JM; Hansen HV; Bysted P; Svehag SE
    J Clin Lab Immunol; 1988 Mar; 25(3):153-6. PubMed ID: 2969415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD21 is a ligand for CD23 and regulates IgE production.
    Aubry JP; Pochon S; Graber P; Jansen KU; Bonnefoy JY
    Nature; 1992 Aug; 358(6386):505-7. PubMed ID: 1386409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C3d and Epstein-Barr virus (CR2/CD21 ligands) stimulate cells of an HTLV-I line, MT-2.
    Kuraya M; Sato T; Fujita T
    Microbiol Immunol; 1995; 39(2):145-51. PubMed ID: 7783687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.